In the last trading session, 18.39 million AEON Biopharma Inc (AMEX:AEON) shares changed hands as the company’s beta touched 0.30. With the company’s per share price at $0.14 changed hands at -$0.05 or -24.03% during last session, the market valuation stood at $11.27M. AEON’s last price was a discount, traded about -12164.29% off its 52-week high of $17.17. The share price had its 52-week low at $0.16, which suggests the last value was -14.29% down since then. When we look at AEON Biopharma Inc’s average trading volume, we note the 10-day average is 17.81 million shares, with the 3-month average coming to 3.03 million.
Analysts gave the AEON Biopharma Inc (AEON) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended AEON as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. AEON Biopharma Inc’s EPS for the current quarter is expected to be -0.18.
AEON Biopharma Inc (AMEX:AEON) trade information
Instantly AEON was in red as seen at the end of in last trading. With action -75.22%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -73.89%, with the 5-day performance at -75.22% in the red. However, in the 30-day time frame, AEON Biopharma Inc (AMEX:AEON) is -77.11% down. Looking at the short shares, we see there were 0.16 million shares sold at short interest cover period of 1.6 days.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
AEON Dividends
AEON Biopharma Inc is expected to release its next quarterly earnings report in February.
AEON Biopharma Inc (AMEX:AEON)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 36.23% of AEON Biopharma Inc shares while 33.14% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 51.98%.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . With 414.9 shares estimated at $58500.0 under it, the former controlled 1.04% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.80% of the shares, roughly 320.9 shares worth around $45246.0.
